Showing results (181-190 of 255) with videos related to
Sort By:
Pageof 26
Journal of Medicinal Chemistry|April 2, 2005
Enantiospecificity of glutamate carboxypeptidase II inhibitionTakashi Tsukamoto, Pavel Majer, Dilrukshi Vitharana, et al.Pharmaceutics|September 28, 2023
Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 MiceMeixiang Huang, Carolyn Tallon, Xiaolei Zhu, et al.Journal of Medicinal Chemistry|January 23, 2025
Discovery of Orally Available Prodrugs of Itaconate and DerivativesChae Bin Lee, Ivan Šnajdr, Lukáš Tenora, et al.Bioorganic & Medicinal Chemistry|December 16, 2018
Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitorsCyril Barinka, Zora Novakova, Niyada Hin, et al.Journal of Medicinal Chemistry|April 14, 2016
Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological ActivityZora Novakova, Krystyna Wozniak, Andrej Jancarik, et al.Science Advances|October 3, 2020
Inhibition of neutral sphingomyelinase 2 promotes remyelinationSeung-Wan Yoo, Amit Agarwal, Matthew D Smith, et al.Cell Reports|October 23, 2015
Preventing Allograft Rejection by Targeting Immune MetabolismChen-Fang Lee, Ying-Chun Lo, Chih-Hsien Cheng, et al.Molecular Imaging|November 16, 2005
High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigenValerie Humblet, Rena Lapidus, Larry R Williams, et al.Cancer Research|November 4, 2010
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1Meghan J Seltzer, Bryson D Bennett, Avadhut D Joshi, et al.Journal of Medicinal Chemistry|July 24, 2015
High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout MiceComfort A Boateng, Oluyomi M Bakare, Jia Zhan, et al.Pageof 26